Relationship Between Ginsenoside Rg3 and Metabolic Syndrome

Hyunji Lee; Hyunji Lee; Gyeyeong Kong; Gyeyeong Kong; Quangdon Tran; Quangdon Tran; Chaeyeong Kim; Chaeyeong Kim; Jisoo Park; Jisoo Park; Jisoo Park; Jongsun Park; Jongsun Park

doi:10.3389/fphar.2020.00130

Frontiers in Pharmacology (Feb 2020)

Relationship Between Ginsenoside Rg3 and Metabolic Syndrome

Hyunji Lee,
Hyunji Lee,
Gyeyeong Kong,
Gyeyeong Kong,
Quangdon Tran,
Quangdon Tran,
Chaeyeong Kim,
Chaeyeong Kim,
Jisoo Park,
Jisoo Park,
Jisoo Park,
Jongsun Park,
Jongsun Park

Affiliations

Hyunji Lee: Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon, South Korea
Hyunji Lee: Department of Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Institute for Cancer Research, College of Medicine, Chungnam National University, Daejeon, South Korea
Gyeyeong Kong: Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon, South Korea
Gyeyeong Kong: Department of Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Institute for Cancer Research, College of Medicine, Chungnam National University, Daejeon, South Korea
Quangdon Tran: Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon, South Korea
Quangdon Tran: Department of Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Institute for Cancer Research, College of Medicine, Chungnam National University, Daejeon, South Korea
Chaeyeong Kim: Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon, South Korea
Chaeyeong Kim: Department of Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Institute for Cancer Research, College of Medicine, Chungnam National University, Daejeon, South Korea
Jisoo Park: Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon, South Korea
Jisoo Park: Department of Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Institute for Cancer Research, College of Medicine, Chungnam National University, Daejeon, South Korea
Jisoo Park: Department of Life Science, Hyehwa Liberal Arts College, Daejeon University, Daejeon, South Korea
Jongsun Park: Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon, South Korea
Jongsun Park: Department of Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Institute for Cancer Research, College of Medicine, Chungnam National University, Daejeon, South Korea

DOI: https://doi.org/10.3389/fphar.2020.00130
Journal volume & issue: Vol. 11

Abstract

Read online

Metabolic syndrome is an important public health issue and is associated with a more affluent lifestyle. Many studies of metabolic syndrome have been reported, but its pathogenesis remains unclear and there is no effective treatment. The ability of natural compounds to ameliorate metabolic syndrome is currently under investigation. Unlike synthetic chemicals, such natural products have proven utility in various fields. Recently, ginsenoside extracted from ginseng and ginseng root are representative examples. For example, ginseng is used in dietary supplements and cosmetics. In addition, various studies have reported the effects of ginsenoside on metabolic syndromes such as obesity, diabetes, and hypertension. In this review, we describe the potential of ginsenoside Rg3, a component of ginseng, in the treatment of metabolic syndrome.

Published in Frontiers in Pharmacology

ISSN: 1663-9812 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: http://journal.frontiersin.org/journals/pharmacology

About the journal

Abstract

Keywords